Downloadable Slides

Share

Program Content

Activities

  • Treatment of HER2-Low Breast Cancer
    Establishing HER2-Targeted Therapies in the Treatment of HER2-Low Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • TROP-2 in breast cancer
    Incorporating TROP-2–Targeted Therapies Into the Breast Cancer Landscape
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • ADC-Associated AEs
    Practical Adverse Event Management for Optimal Therapeutic Outcomes
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

Faculty

cover img faculity

Aditya Bardia, MD, MPH, FASCO

Program Director, Breast Medical Oncology
Assistant Chief (Translational Research), Division of Hematology-Oncology
Professor of Medicine, Geffen School of Medicine, University of California Los Angeles
Director of Translational Research Integration, UCLA Health Jonsson Comprehensive Center
Los Angeles, California

cover img faculity

Sara A. Hurvitz, MD, FACP

Professor of Medicine
Head, Division of Hematology and Oncology
Department of Medicine, UW Medicine
Senior Vice President
Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington

cover img faculity

Shanu Modi, MD

Professor of Medicine
Section Head, HER2 Breast Program
Breast Medicine Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
New York, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.

AstraZeneca

Daiichi Sankyo

Gilead Sciences, Inc.